Early intravenous beta-blockers for acute myocardial infarction

Early intravenous beta-blockers for acute myocardial infarction


Shu Hong Guo, Yi He and Qiang Fu*

Cardiovascular Department, Zhuzhou Central Hospital, Zhuzhou 412007, China



Journal of Clinical & Experimental Cardiology



Early intravenous beta-blockers reduce the risk of recurrent ischaemia and ventricular arrhythmia in the treatment of acute myocardial infarction. These beneficial efficacy, however, are balanced by a high rate of cardiogenic shock. It has great significance for reliable identification of subgroups of patients among whom treatment is really advantageous. The present article is a review on the efficacy and safety of the early intravenous beta-blockers, and provides an evaluation procedure to guide clinicians applying intravenous beta-blockers to clinical practice.



Beta-blockers; Acute myocardial infarction

Read the whole article in the PDF file BELOW



© 2017 Guo SH, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Fișiere atașate